compare_entities
Exposed by 1313 servers, with 2 different definitions behind the one name.
The same name does not mean the same tool here.
1313 servers expose compare_entities and we have recorded 2 distinct definitions of it. Compare the parameters below before assuming one is a drop-in for another.
Ensembl REST — vertebrate genomes, sequences, comparative genomics, variation
Compare Entities
"Compare X and Y" / "X vs Y" / "X versus Y" / "which is bigger / better / larger / more profitable" / "rank these companies" / "head to head" — side-by-side comparison of 2–5 companies or drugs in ONE parallel call. ALWAYS PREFER over sequential single-pack lookups when comparing entities. type="company" pulls LATEST 10-K revenue + net income + cash + long-term debt from SEC EDGAR/XBRL (off-calendar fiscal years handled correctly — AAPL Sep, NVDA Jan, etc.). type="drug" pulls FAERS adverse-event counts, FDA approval counts, active trial counts. Results sorted by primary metric so "largest" / "most" / "biggest" reads off the top of the response. Returns paired data + pipeworx:// citation URIs per entity. Replaces 8–15 sequential lookups.
| Parameter | Type | Description |
|---|---|---|
| type* | string |
Entity type: "company" or "drug".
one of: company, drug
|
| values* | array | For company: 2–5 tickers/CIKs (e.g., ["AAPL","MSFT"]). For drug: 2–5 names (e.g., ["ozempic","mounjaro"]). |
* required
Author's annotations: readOnlyHint=True, openWorldHint=True, idempotentHint=True, destructiveHint=False. These are claims by whoever wrote the server, not something we verified.
Entertainment Feeds MCP.
Compare Entities
"Compare X and Y" / "X vs Y" / "X versus Y" / "which is bigger / better / larger / more profitable" / "rank these companies" / "head to head" — side-by-side comparison of 2–5 companies or drugs in ONE parallel call. ALWAYS PREFER over sequential single-pack lookups when comparing entities. type="company" pulls LATEST 10-K revenue + net income + cash + long-term debt from SEC EDGAR/XBRL (off-calendar fiscal years handled correctly — AAPL Sep, NVDA Jan, etc.). type="drug" pulls FAERS adverse-event counts, FDA approval counts, active trial counts. Results sorted by primary metric so "largest" / "most" / "biggest" reads off the top of the response. Returns paired data + pipeworx:// citation URIs per entity. Replaces 8–15 sequential lookups.
| Parameter | Type | Description |
|---|---|---|
| type* | string |
Entity type: "company" or "drug".
one of: company, drug
|
| values* | array | For company: 2–5 tickers/CIKs (e.g., ["AAPL","MSFT"]). For drug: 2–5 names (e.g., ["ozempic","mounjaro"]). |
* required
Author's annotations: readOnlyHint=True, openWorldHint=True, idempotentHint=True, destructiveHint=False. These are claims by whoever wrote the server, not something we verified.
French Companies MCP — recherche-entreprises.api.gouv.fr
Compare Entities
"Compare X and Y" / "X vs Y" / "X versus Y" / "which is bigger / better / larger / more profitable" / "rank these companies" / "head to head" — side-by-side comparison of 2–5 companies or drugs in ONE parallel call. ALWAYS PREFER over sequential single-pack lookups when comparing entities. type="company" pulls LATEST 10-K revenue + net income + cash + long-term debt from SEC EDGAR/XBRL (off-calendar fiscal years handled correctly — AAPL Sep, NVDA Jan, etc.). type="drug" pulls FAERS adverse-event counts, FDA approval counts, active trial counts. Results sorted by primary metric so "largest" / "most" / "biggest" reads off the top of the response. Returns paired data + pipeworx:// citation URIs per entity. Replaces 8–15 sequential lookups.
| Parameter | Type | Description |
|---|---|---|
| type* | string |
Entity type: "company" or "drug".
one of: company, drug
|
| values* | array | For company: 2–5 tickers/CIKs (e.g., ["AAPL","MSFT"]). For drug: 2–5 names (e.g., ["ozempic","mounjaro"]). |
* required
Author's annotations: readOnlyHint=True, openWorldHint=True, idempotentHint=True, destructiveHint=False. These are claims by whoever wrote the server, not something we verified.
ENTSO-E Transparency Platform MCP
Compare Entities
"Compare X and Y" / "X vs Y" / "X versus Y" / "which is bigger / better / larger / more profitable" / "rank these companies" / "head to head" — side-by-side comparison of 2–5 companies or drugs in ONE parallel call. ALWAYS PREFER over sequential single-pack lookups when comparing entities. type="company" pulls LATEST 10-K revenue + net income + cash + long-term debt from SEC EDGAR/XBRL (off-calendar fiscal years handled correctly — AAPL Sep, NVDA Jan, etc.). type="drug" pulls FAERS adverse-event counts, FDA approval counts, active trial counts. Results sorted by primary metric so "largest" / "most" / "biggest" reads off the top of the response. Returns paired data + pipeworx:// citation URIs per entity. Replaces 8–15 sequential lookups.
| Parameter | Type | Description |
|---|---|---|
| type* | string |
Entity type: "company" or "drug".
one of: company, drug
|
| values* | array | For company: 2–5 tickers/CIKs (e.g., ["AAPL","MSFT"]). For drug: 2–5 names (e.g., ["ozempic","mounjaro"]). |
* required
Author's annotations: readOnlyHint=True, openWorldHint=True, idempotentHint=True, destructiveHint=False. These are claims by whoever wrote the server, not something we verified.
Entur MCP — Norway public transport, nationwide, all modes (developer.entur.org)
Compare Entities
"Compare X and Y" / "X vs Y" / "X versus Y" / "which is bigger / better / larger / more profitable" / "rank these companies" / "head to head" — side-by-side comparison of 2–5 companies or drugs in ONE parallel call. ALWAYS PREFER over sequential single-pack lookups when comparing entities. type="company" pulls LATEST 10-K revenue + net income + cash + long-term debt from SEC EDGAR/XBRL (off-calendar fiscal years handled correctly — AAPL Sep, NVDA Jan, etc.). type="drug" pulls FAERS adverse-event counts, FDA approval counts, active trial counts. Results sorted by primary metric so "largest" / "most" / "biggest" reads off the top of the response. Returns paired data + pipeworx:// citation URIs per entity. Replaces 8–15 sequential lookups.
| Parameter | Type | Description |
|---|---|---|
| type* | string |
Entity type: "company" or "drug".
one of: company, drug
|
| values* | array | For company: 2–5 tickers/CIKs (e.g., ["AAPL","MSFT"]). For drug: 2–5 names (e.g., ["ozempic","mounjaro"]). |
* required
Author's annotations: readOnlyHint=True, openWorldHint=True, idempotentHint=True, destructiveHint=False. These are claims by whoever wrote the server, not something we verified.
EODHD MCP — wraps EOD Historical Data (eodhd.com)
Compare Entities
"Compare X and Y" / "X vs Y" / "X versus Y" / "which is bigger / better / larger / more profitable" / "rank these companies" / "head to head" — side-by-side comparison of 2–5 companies or drugs in ONE parallel call. ALWAYS PREFER over sequential single-pack lookups when comparing entities. type="company" pulls LATEST 10-K revenue + net income + cash + long-term debt from SEC EDGAR/XBRL (off-calendar fiscal years handled correctly — AAPL Sep, NVDA Jan, etc.). type="drug" pulls FAERS adverse-event counts, FDA approval counts, active trial counts. Results sorted by primary metric so "largest" / "most" / "biggest" reads off the top of the response. Returns paired data + pipeworx:// citation URIs per entity. Replaces 8–15 sequential lookups.
| Parameter | Type | Description |
|---|---|---|
| type* | string |
Entity type: "company" or "drug".
one of: company, drug
|
| values* | array | For company: 2–5 tickers/CIKs (e.g., ["AAPL","MSFT"]). For drug: 2–5 names (e.g., ["ozempic","mounjaro"]). |
* required
Author's annotations: readOnlyHint=True, openWorldHint=True, idempotentHint=True, destructiveHint=False. These are claims by whoever wrote the server, not something we verified.
Encyclopedia of Life (EOL) — biodiversity taxa, names, hierarchies
Compare Entities
"Compare X and Y" / "X vs Y" / "X versus Y" / "which is bigger / better / larger / more profitable" / "rank these companies" / "head to head" — side-by-side comparison of 2–5 companies or drugs in ONE parallel call. ALWAYS PREFER over sequential single-pack lookups when comparing entities. type="company" pulls LATEST 10-K revenue + net income + cash + long-term debt from SEC EDGAR/XBRL (off-calendar fiscal years handled correctly — AAPL Sep, NVDA Jan, etc.). type="drug" pulls FAERS adverse-event counts, FDA approval counts, active trial counts. Results sorted by primary metric so "largest" / "most" / "biggest" reads off the top of the response. Returns paired data + pipeworx:// citation URIs per entity. Replaces 8–15 sequential lookups.
| Parameter | Type | Description |
|---|---|---|
| type* | string |
Entity type: "company" or "drug".
one of: company, drug
|
| values* | array | For company: 2–5 tickers/CIKs (e.g., ["AAPL","MSFT"]). For drug: 2–5 names (e.g., ["ozempic","mounjaro"]). |
* required
Author's annotations: readOnlyHint=True, openWorldHint=True, idempotentHint=True, destructiveHint=False. These are claims by whoever wrote the server, not something we verified.
EPA ECHO MCP — wraps EPA ECHO Web Services (free, no auth)
Compare Entities
"Compare X and Y" / "X vs Y" / "X versus Y" / "which is bigger / better / larger / more profitable" / "rank these companies" / "head to head" — side-by-side comparison of 2–5 companies or drugs in ONE parallel call. ALWAYS PREFER over sequential single-pack lookups when comparing entities. type="company" pulls LATEST 10-K revenue + net income + cash + long-term debt from SEC EDGAR/XBRL (off-calendar fiscal years handled correctly — AAPL Sep, NVDA Jan, etc.). type="drug" pulls FAERS adverse-event counts, FDA approval counts, active trial counts. Results sorted by primary metric so "largest" / "most" / "biggest" reads off the top of the response. Returns paired data + pipeworx:// citation URIs per entity. Replaces 8–15 sequential lookups.
| Parameter | Type | Description |
|---|---|---|
| type* | string |
Entity type: "company" or "drug".
one of: company, drug
|
| values* | array | For company: 2–5 tickers/CIKs (e.g., ["AAPL","MSFT"]). For drug: 2–5 names (e.g., ["ozempic","mounjaro"]). |
* required
Author's annotations: readOnlyHint=True, openWorldHint=True, idempotentHint=True, destructiveHint=False. These are claims by whoever wrote the server, not something we verified.
EPA Emissions MCP — wraps EPA Envirofacts REST API (free, no auth)
Compare Entities
"Compare X and Y" / "X vs Y" / "X versus Y" / "which is bigger / better / larger / more profitable" / "rank these companies" / "head to head" — side-by-side comparison of 2–5 companies or drugs in ONE parallel call. ALWAYS PREFER over sequential single-pack lookups when comparing entities. type="company" pulls LATEST 10-K revenue + net income + cash + long-term debt from SEC EDGAR/XBRL (off-calendar fiscal years handled correctly — AAPL Sep, NVDA Jan, etc.). type="drug" pulls FAERS adverse-event counts, FDA approval counts, active trial counts. Results sorted by primary metric so "largest" / "most" / "biggest" reads off the top of the response. Returns paired data + pipeworx:// citation URIs per entity. Replaces 8–15 sequential lookups.
| Parameter | Type | Description |
|---|---|---|
| type* | string |
Entity type: "company" or "drug".
one of: company, drug
|
| values* | array | For company: 2–5 tickers/CIKs (e.g., ["AAPL","MSFT"]). For drug: 2–5 names (e.g., ["ozempic","mounjaro"]). |
* required
Author's annotations: readOnlyHint=True, openWorldHint=True, idempotentHint=True, destructiveHint=False. These are claims by whoever wrote the server, not something we verified.
US EPA Envirofacts MCP.
Compare Entities
"Compare X and Y" / "X vs Y" / "X versus Y" / "which is bigger / better / larger / more profitable" / "rank these companies" / "head to head" — side-by-side comparison of 2–5 companies or drugs in ONE parallel call. ALWAYS PREFER over sequential single-pack lookups when comparing entities. type="company" pulls LATEST 10-K revenue + net income + cash + long-term debt from SEC EDGAR/XBRL (off-calendar fiscal years handled correctly — AAPL Sep, NVDA Jan, etc.). type="drug" pulls FAERS adverse-event counts, FDA approval counts, active trial counts. Results sorted by primary metric so "largest" / "most" / "biggest" reads off the top of the response. Returns paired data + pipeworx:// citation URIs per entity. Replaces 8–15 sequential lookups.
| Parameter | Type | Description |
|---|---|---|
| type* | string |
Entity type: "company" or "drug".
one of: company, drug
|
| values* | array | For company: 2–5 tickers/CIKs (e.g., ["AAPL","MSFT"]). For drug: 2–5 names (e.g., ["ozempic","mounjaro"]). |
* required
Author's annotations: readOnlyHint=True, openWorldHint=True, idempotentHint=True, destructiveHint=False. These are claims by whoever wrote the server, not something we verified.
EPA Regulations MCP — US Environmental Protection Agency regulations (40 CFR).
Compare Entities
"Compare X and Y" / "X vs Y" / "X versus Y" / "which is bigger / better / larger / more profitable" / "rank these companies" / "head to head" — side-by-side comparison of 2–5 companies or drugs in ONE parallel call. ALWAYS PREFER over sequential single-pack lookups when comparing entities. type="company" pulls LATEST 10-K revenue + net income + cash + long-term debt from SEC EDGAR/XBRL (off-calendar fiscal years handled correctly — AAPL Sep, NVDA Jan, etc.). type="drug" pulls FAERS adverse-event counts, FDA approval counts, active trial counts. Results sorted by primary metric so "largest" / "most" / "biggest" reads off the top of the response. Returns paired data + pipeworx:// citation URIs per entity. Replaces 8–15 sequential lookups.
| Parameter | Type | Description |
|---|---|---|
| type* | string |
Entity type: "company" or "drug".
one of: company, drug
|
| values* | array | For company: 2–5 tickers/CIKs (e.g., ["AAPL","MSFT"]). For drug: 2–5 names (e.g., ["ozempic","mounjaro"]). |
* required
Author's annotations: readOnlyHint=True, openWorldHint=True, idempotentHint=True, destructiveHint=False. These are claims by whoever wrote the server, not something we verified.
EPO Open Patent Services MCP
Compare Entities
"Compare X and Y" / "X vs Y" / "X versus Y" / "which is bigger / better / larger / more profitable" / "rank these companies" / "head to head" — side-by-side comparison of 2–5 companies or drugs in ONE parallel call. ALWAYS PREFER over sequential single-pack lookups when comparing entities. type="company" pulls LATEST 10-K revenue + net income + cash + long-term debt from SEC EDGAR/XBRL (off-calendar fiscal years handled correctly — AAPL Sep, NVDA Jan, etc.). type="drug" pulls FAERS adverse-event counts, FDA approval counts, active trial counts. Results sorted by primary metric so "largest" / "most" / "biggest" reads off the top of the response. Returns paired data + pipeworx:// citation URIs per entity. Replaces 8–15 sequential lookups.
| Parameter | Type | Description |
|---|---|---|
| type* | string |
Entity type: "company" or "drug".
one of: company, drug
|
| values* | array | For company: 2–5 tickers/CIKs (e.g., ["AAPL","MSFT"]). For drug: 2–5 names (e.g., ["ozempic","mounjaro"]). |
* required
Author's annotations: readOnlyHint=True, openWorldHint=True, idempotentHint=True, destructiveHint=False. These are claims by whoever wrote the server, not something we verified.
FIRST.org EPSS (Exploit Prediction Scoring System) MCP.
Compare Entities
"Compare X and Y" / "X vs Y" / "X versus Y" / "which is bigger / better / larger / more profitable" / "rank these companies" / "head to head" — side-by-side comparison of 2–5 companies or drugs in ONE parallel call. ALWAYS PREFER over sequential single-pack lookups when comparing entities. type="company" pulls LATEST 10-K revenue + net income + cash + long-term debt from SEC EDGAR/XBRL (off-calendar fiscal years handled correctly — AAPL Sep, NVDA Jan, etc.). type="drug" pulls FAERS adverse-event counts, FDA approval counts, active trial counts. Results sorted by primary metric so "largest" / "most" / "biggest" reads off the top of the response. Returns paired data + pipeworx:// citation URIs per entity. Replaces 8–15 sequential lookups.
| Parameter | Type | Description |
|---|---|---|
| type* | string |
Entity type: "company" or "drug".
one of: company, drug
|
| values* | array | For company: 2–5 tickers/CIKs (e.g., ["AAPL","MSFT"]). For drug: 2–5 names (e.g., ["ozempic","mounjaro"]). |
* required
Author's annotations: readOnlyHint=True, openWorldHint=True, idempotentHint=True, destructiveHint=False. These are claims by whoever wrote the server, not something we verified.
ESPN MCP — keyless multi-sport live scores, teams, and news via ESPN's public site API.
Compare Entities
"Compare X and Y" / "X vs Y" / "X versus Y" / "which is bigger / better / larger / more profitable" / "rank these companies" / "head to head" — side-by-side comparison of 2–5 companies or drugs in ONE parallel call. ALWAYS PREFER over sequential single-pack lookups when comparing entities. type="company" pulls LATEST 10-K revenue + net income + cash + long-term debt from SEC EDGAR/XBRL (off-calendar fiscal years handled correctly — AAPL Sep, NVDA Jan, etc.). type="drug" pulls FAERS adverse-event counts, FDA approval counts, active trial counts. Results sorted by primary metric so "largest" / "most" / "biggest" reads off the top of the response. Returns paired data + pipeworx:// citation URIs per entity. Replaces 8–15 sequential lookups.
| Parameter | Type | Description |
|---|---|---|
| type* | string |
Entity type: "company" or "drug".
one of: company, drug
|
| values* | array | For company: 2–5 tickers/CIKs (e.g., ["AAPL","MSFT"]). For drug: 2–5 names (e.g., ["ozempic","mounjaro"]). |
* required
Author's annotations: readOnlyHint=True, openWorldHint=True, idempotentHint=True, destructiveHint=False. These are claims by whoever wrote the server, not something we verified.
e-Stat (Japan) MCP — government statistics
Compare Entities
"Compare X and Y" / "X vs Y" / "X versus Y" / "which is bigger / better / larger / more profitable" / "rank these companies" / "head to head" — side-by-side comparison of 2–5 companies or drugs in ONE parallel call. ALWAYS PREFER over sequential single-pack lookups when comparing entities. type="company" pulls LATEST 10-K revenue + net income + cash + long-term debt from SEC EDGAR/XBRL (off-calendar fiscal years handled correctly — AAPL Sep, NVDA Jan, etc.). type="drug" pulls FAERS adverse-event counts, FDA approval counts, active trial counts. Results sorted by primary metric so "largest" / "most" / "biggest" reads off the top of the response. Returns paired data + pipeworx:// citation URIs per entity. Replaces 8–15 sequential lookups.
| Parameter | Type | Description |
|---|---|---|
| type* | string |
Entity type: "company" or "drug".
one of: company, drug
|
| values* | array | For company: 2–5 tickers/CIKs (e.g., ["AAPL","MSFT"]). For drug: 2–5 names (e.g., ["ozempic","mounjaro"]). |
* required
Author's annotations: readOnlyHint=True, openWorldHint=True, idempotentHint=True, destructiveHint=False. These are claims by whoever wrote the server, not something we verified.
Etherscan MCP — multichain block-explorer API (Etherscan V2)
Compare Entities
"Compare X and Y" / "X vs Y" / "X versus Y" / "which is bigger / better / larger / more profitable" / "rank these companies" / "head to head" — side-by-side comparison of 2–5 companies or drugs in ONE parallel call. ALWAYS PREFER over sequential single-pack lookups when comparing entities. type="company" pulls LATEST 10-K revenue + net income + cash + long-term debt from SEC EDGAR/XBRL (off-calendar fiscal years handled correctly — AAPL Sep, NVDA Jan, etc.). type="drug" pulls FAERS adverse-event counts, FDA approval counts, active trial counts. Results sorted by primary metric so "largest" / "most" / "biggest" reads off the top of the response. Returns paired data + pipeworx:// citation URIs per entity. Replaces 8–15 sequential lookups.
| Parameter | Type | Description |
|---|---|---|
| type* | string |
Entity type: "company" or "drug".
one of: company, drug
|
| values* | array | For company: 2–5 tickers/CIKs (e.g., ["AAPL","MSFT"]). For drug: 2–5 names (e.g., ["ozempic","mounjaro"]). |
* required
Author's annotations: readOnlyHint=True, openWorldHint=True, idempotentHint=True, destructiveHint=False. These are claims by whoever wrote the server, not something we verified.
EU Funding & Tenders Portal (SEDIA search API) MCP.
Compare Entities
"Compare X and Y" / "X vs Y" / "X versus Y" / "which is bigger / better / larger / more profitable" / "rank these companies" / "head to head" — side-by-side comparison of 2–5 companies or drugs in ONE parallel call. ALWAYS PREFER over sequential single-pack lookups when comparing entities. type="company" pulls LATEST 10-K revenue + net income + cash + long-term debt from SEC EDGAR/XBRL (off-calendar fiscal years handled correctly — AAPL Sep, NVDA Jan, etc.). type="drug" pulls FAERS adverse-event counts, FDA approval counts, active trial counts. Results sorted by primary metric so "largest" / "most" / "biggest" reads off the top of the response. Returns paired data + pipeworx:// citation URIs per entity. Replaces 8–15 sequential lookups.
| Parameter | Type | Description |
|---|---|---|
| type* | string |
Entity type: "company" or "drug".
one of: company, drug
|
| values* | array | For company: 2–5 tickers/CIKs (e.g., ["AAPL","MSFT"]). For drug: 2–5 names (e.g., ["ozempic","mounjaro"]). |
* required
Author's annotations: readOnlyHint=True, openWorldHint=True, idempotentHint=True, destructiveHint=False. These are claims by whoever wrote the server, not something we verified.
European Parliament Open Data — MEPs, plenary docs, sessions
Compare Entities
"Compare X and Y" / "X vs Y" / "X versus Y" / "which is bigger / better / larger / more profitable" / "rank these companies" / "head to head" — side-by-side comparison of 2–5 companies or drugs in ONE parallel call. ALWAYS PREFER over sequential single-pack lookups when comparing entities. type="company" pulls LATEST 10-K revenue + net income + cash + long-term debt from SEC EDGAR/XBRL (off-calendar fiscal years handled correctly — AAPL Sep, NVDA Jan, etc.). type="drug" pulls FAERS adverse-event counts, FDA approval counts, active trial counts. Results sorted by primary metric so "largest" / "most" / "biggest" reads off the top of the response. Returns paired data + pipeworx:// citation URIs per entity. Replaces 8–15 sequential lookups.
| Parameter | Type | Description |
|---|---|---|
| type* | string |
Entity type: "company" or "drug".
one of: company, drug
|
| values* | array | For company: 2–5 tickers/CIKs (e.g., ["AAPL","MSFT"]). For drug: 2–5 names (e.g., ["ozempic","mounjaro"]). |
* required
Author's annotations: readOnlyHint=True, openWorldHint=True, idempotentHint=True, destructiveHint=False. These are claims by whoever wrote the server, not something we verified.
EU law, article-level: GDPR, NIS2, DORA, EU AI Act + more, with EUR-Lex citations. Keyless.
Compare Entities
"Compare X and Y" / "X vs Y" / "X versus Y" / "which is bigger / better / larger / more profitable" / "rank these companies" / "head to head" — side-by-side comparison of 2–5 companies or drugs in ONE parallel call. ALWAYS PREFER over sequential single-pack lookups when comparing entities. type="company" pulls LATEST 10-K revenue + net income + cash + long-term debt from SEC EDGAR/XBRL (off-calendar fiscal years handled correctly — AAPL Sep, NVDA Jan, etc.). type="drug" pulls FAERS adverse-event counts, FDA approval counts, active trial counts. Results sorted by primary metric so "largest" / "most" / "biggest" reads off the top of the response. Returns paired data + pipeworx:// citation URIs per entity. Replaces 8–15 sequential lookups.
| Parameter | Type | Description |
|---|---|---|
| type* | string |
Entity type: "company" or "drug".
one of: company, drug
|
| values* | array | For company: 2–5 tickers/CIKs (e.g., ["AAPL","MSFT"]). For drug: 2–5 names (e.g., ["ozempic","mounjaro"]). |
* required
Author's annotations: readOnlyHint=True, openWorldHint=True, idempotentHint=True, destructiveHint=False. These are claims by whoever wrote the server, not something we verified.
Europeana MCP.
Compare Entities
"Compare X and Y" / "X vs Y" / "X versus Y" / "which is bigger / better / larger / more profitable" / "rank these companies" / "head to head" — side-by-side comparison of 2–5 companies or drugs in ONE parallel call. ALWAYS PREFER over sequential single-pack lookups when comparing entities. type="company" pulls LATEST 10-K revenue + net income + cash + long-term debt from SEC EDGAR/XBRL (off-calendar fiscal years handled correctly — AAPL Sep, NVDA Jan, etc.). type="drug" pulls FAERS adverse-event counts, FDA approval counts, active trial counts. Results sorted by primary metric so "largest" / "most" / "biggest" reads off the top of the response. Returns paired data + pipeworx:// citation URIs per entity. Replaces 8–15 sequential lookups.
| Parameter | Type | Description |
|---|---|---|
| type* | string |
Entity type: "company" or "drug".
one of: company, drug
|
| values* | array | For company: 2–5 tickers/CIKs (e.g., ["AAPL","MSFT"]). For drug: 2–5 names (e.g., ["ozempic","mounjaro"]). |
* required
Author's annotations: readOnlyHint=True, openWorldHint=True, idempotentHint=True, destructiveHint=False. These are claims by whoever wrote the server, not something we verified.
What this page is
Every field above is reproduced as the server published it at the time shown. The description and the annotations are claims by the server's author. Toolpin does not call tools, so we cannot tell you whether a tool does what it says.
What we can tell you is whether the claim changed. The hash covers the fields the MCP specification defines, so a vendor build stamp does not move it but a rewritten description does. See how we monitor, or this server's change history.